5 Heart Attack Clinical Trials in Aventura, FL (2026)

Q: How do I join a clinical trial in Aventura?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Aventura research site will contact you.

Recruiting Heart Attack Studies in Aventura

NCT06584357Recruiting

Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia

Bio-Hermes-002 is a 120-day cross-sectional study that will result in a blood, CSF, retinal, digital, MRI, and PET brain imaging biomarker database that can be used to determine the primary objective....

Aventura, FL1,200 participantsGAP Innovations, PBC

View Study Details

NCT06641466Recruiting

A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine

The purpose of this study is to evaluate the efficacy and safety of rimegepant when administered during the peri-menstrual period (PMP) for intermittent prevention of migraine in women who experience ...

Aventura, FLPHASE3723 participantsPfizer

View Study Details

NCT07438496Recruiting

A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus

The purpose of this study is to evaluate how well nipocalimab works as compared to placebo in participants with moderate to severe Systemic lupus erythematosus (SLE, a long-term disease where the immu...

Aventura, FLPHASE3600 participantsJanssen Research & Development, LLC

View Study Details

NCT07409181Recruiting

A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)

This study is open to adults with systemic lupus erythematosus (SLE). The purpose of this study is to find out whether a medicine called BI 3000202 helps people with SLE. The study tests different dos...

Aventura, FLPHASE2405 participantsBoehringer Ingelheim

View Study Details

NCT06311227Recruiting

Venetoclax for the Treatment of Patients With Relapsed Hairy Cell Leukemia

This phase II trial tests how well venetoclax works in treating patients with hairy cell leukemia that has come back after a period of improvement (relapsed). Venetoclax is in a class of medications c...

Aventura, FLPHASE220 participantsNational Cancer Institute (NCI)

View Study Details

About Heart Attack Clinical Trials in Aventura

A heart attack (myocardial infarction) occurs when blood flow to part of the heart muscle is blocked, usually by a blood clot. It is a medical emergency requiring immediate treatment. Long-term management includes medications, lifestyle changes, and cardiac rehabilitation.

There are currently 5 heart attack clinical trials recruiting participants in Aventura, FL. These studies are seeking a combined 2,948 participants. Research is being sponsored by GAP Innovations, PBC, Pfizer, Janssen Research & Development, LLC and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Heart Attack Clinical Trials in Aventura — FAQ

Are there heart attack clinical trials in Aventura?

Yes, there are 5 heart attack clinical trials currently recruiting in Aventura, FL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Aventura?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Aventura research site will contact you about next steps.

Are clinical trials in Aventura free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Aventura studies also compensate for your time and travel.

What heart attack treatments are being tested?

The 5 active trials in Aventura are testing new therapies including novel drugs, biologics, and treatment approaches for heart attack.

Data updated July 22, 2026 from ClinicalTrials.gov